Larson Financial Group’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History
Bought
Maintained
Sold
Other funds holding ORTX
RCM
DM
CA
APM
CC
AG
Larson Financial Group's ORTX Position: Q3 2021 in Review
Larson Financial Group sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q3 2021, closing a stake of 33 shares — an estimated $1K sold.
Larson Financial Group first reported a position in ORTX in Q2 2021 and held it in 1 quarter. The position peaked at $1K in Q2 2021. 79 funds tracked by Wall St. Rank hold ORTX as of Q3 2021.
- Larson Financial Group reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q3 2021 after selling out during the quarter.
- Larson Financial Group sold 33 Orchard Therapeutics plc American Depositary Shares shares in Q3 2021, an estimated $1K.
- Larson Financial Group first reported a position in Orchard Therapeutics plc American Depositary Shares in Q2 2021 and held it in 1 quarter.
- Larson Financial Group's Orchard Therapeutics plc American Depositary Shares position peaked at $1K in Q2 2021.
- 79 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q3 2021.
Based on Larson Financial Group's 13F filing for Q3 2021, filed 4 Nov 2021.